- Report
- August 2025
- 192 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 197 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 184 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 186 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 187 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 189 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 199 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 183 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 193 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 182 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 180 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 188 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 190 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 182 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 197 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 192 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2117EUR$2,400USD£1,854GBP
€2647EUR$3,000USD£2,318GBP
- Report
- May 2025
- 120 Pages
Global
From €4191EUR$4,750USD£3,670GBP
- Report
- December 2025
- 481 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- December 2025
- 282 Pages
Global
From €5161EUR$5,850USD£4,519GBP

The Peptide market is a subset of the biopharmaceutical industry, which focuses on the development and production of therapeutic proteins and peptides. Peptides are short chains of amino acids that are used to treat a variety of diseases, including cancer, diabetes, and autoimmune disorders. Peptides are typically produced through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Peptide market is highly competitive, with a number of companies offering a variety of products. Companies in the market are focused on developing and manufacturing peptides for therapeutic use, as well as providing services such as peptide synthesis and purification. Additionally, some companies are involved in the development of peptide-based drug delivery systems.
Notable companies in the Peptide market include Novo Nordisk, Merck, Sanofi, and Pfizer. Other companies include AbbVie, Amgen, and Genentech. Show Less Read more